ESC Professional Premium Access

Semaglutide modulates pro-inflammatory neutrophil phenotype induced by supraphysiological levels of the adipokine FABP4 in patients with cardiovascular disease.

Congress Presentation

About the speaker

Doctor Sonia Eiras

Health Research Institute, Santiago de Compostela (Spain)
1 follower

7 more presentations in this session

Human epicardial adipose tissue-derived factors promote atrial endothelial dysfunction: role of pro-inflammatory cytokines and AT1R/NADPH oxidases/SGLT2 pro-oxidant pathway

Speaker: Doctor W. Fakih (Strasbourg, FR)

Thumbnail

Takotsubo syndrome induced oxidative stress and endothelial dysfunction in left ventricle of rat model: association with NADPH oxidases/SGLT2 pro- oxidant pathway

Speaker: Miss T. Tatarcheh (Strasbourg, FR)

Thumbnail

Investigating the effects of empagliflozin on myocardial metabolic and lipid profile in healthy and metabolic syndrome murine models following acute myocardial infarction

Speaker: Professor I. Andreadou (Athens, GR)

Thumbnail

Semaglutide improves contractile function in isolated human atrium

Speaker: Doctor P. Hegner (Regensburg, DE)

Thumbnail

Effects of empagliflozin on cardio-renal interaction in heart failure with reduced ejection fraction: results from in-vivo experiments and the CINNAMON-study

Speaker: Doctor F. Sinha (Regensburg, DE)

Thumbnail

Access the full session

Antidiabetic drugs for treatment of cardiovascular disease

Speakers: Doctor S. Eiras, Doctor W. Fakih, Miss T. Tatarcheh, Professor I. Andreadou, Doctor P. Hegner...
Thumbnail

About the event

Image

ESC Congress 2024

30 August - 2 September 2024

Sessions Presentations